Locating pain in breast cancer survivors experiencing dyspareunia: A randomized controlled trial

Obstetrics and Gynecology

Volumn 123, Issue 6, 2014, Pages 1231-1236

  Goetsch, Martha F ^a   Lim, Jeong Y ^a   Caughey, Aaron B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PAIN; CANCER SURVIVOR; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPAREUNIA; FEMALE; HUMAN; MYALGIA; PELVIS FLOOR; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA; VAGINA ATROPHY; VAGINA DISCHARGE; VESTIBULE;

ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; BREAST NEOPLASMS; DOUBLE-BLIND METHOD; DYSPAREUNIA; FEMALE; HUMANS; LIDOCAINE; MIDDLE AGED; PHYSICAL EXAMINATION; SURVIVORS; VULVA; VULVAR VESTIBULITIS;

EID: 84901620608     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000283     Document Type: Article

References (16)

1. Fobair P, Spiegel D. Concerns about sexuality after breast cancer. Cancer J 2009;15:19-26.
2. Haefner H, Collins M, Davis G, Edwards L, Forster D, Hartmann E, et al. The vulvodynia guideline. J Low Genit Tract Dis 2005;9:40-51.
3. Landry T, Bergeron S, Dupuis M, Desrochers G. The treatment of provoked vestibulodynia: a critical review. Clin J Pain 2008; 24:155-71.
4. Kao A, Binik Y, Kapuscinski A, Khalifé S. Dyspareunia in postmenopausal women: a critical review. Pain Res Manag 2008;13: 243-54.
5. Leclair CM, Goetsch MF, Li H, Morgan TK. Histopathologic characteristics of menopausal vestibulodynia. Obstet Gynecol 2013;122:787-93.
6. Bergeron C, Binik Y, Khalife S, Pagidas K, Glazer H. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001;98:45-51.
7. Meana M, Binik Y. Painful coitus: a review of female dyspareunia. J Nerv Ment Dis 1994;182:264-72.
8. Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.
9. Danielsson I, Torstensson T, Brodda-Jansen G, Bohm-Starke N. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand 2006;85:1360-7.
10. Dworkin R, Turk D, Wyrwich K, Beaton D, Cleeland C, Farrar J. Interpreting the clinical importance of treatment outcomes in chronic pain clinical Trials: IMMPACT recommendations. J Pain 2008;9:105-21.
11. Roy S, Caillouette J, Roy T, Faden J. Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol 2004;190:1272-7.
12. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888-902.
13. Steege JF, Zolnoun DA. Evaluation and treatment of dyspareunia. Obstet Gynecol 2009;113:1124-36.
14. Robboy S, Bentley R, Russell P. Embryology of the female genital tract and disorders of abnormal sexual development. In: Kurman R, editor. Blaustein's pathology of the female genital tract. New York (NY): Springer; 2002.
15. Kao A, Binik Y, Amsel R, Funaro D, Leroux N, Khalifé S. Challenging atrophied perspectives on postmenopausal dyspareunia: a systematic description and synthesis of pain characteristics. J Sex Marital Ther 2012;38:128-50.
16. Friedrich E. Vulvar vestibulitis syndrome. J Reprod Med 1987; 32:110-4.